Arrowhead Pharmaceuticals, Inc.

US$58.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ARWRHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 25.87%
Div yield —
ROE (55.21%)
Biotechnology
Beta (5Y) 1.37
PE TTM —
TSR TTM 37.20%
Mkt cap US$8.215B
ROIC (101.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$59
1.27%
(32.15%)
Hold 8|3|11|0|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.86
0.89
1.00
0.96
17.42%
27.62%
31.70%
24.61%
Revenue$M
891.0
876.9
908.9
916.0
4.80%
3.27%
6.37%
3.11%
Peers (US$8.215B)
Cap (US$)
PE
8.486B
21.61x
Capital
TTM
5Y
10Y
Leveragex
0.626
(0.069)
(0.058)
EBIT/Intx
1.267
0.138
0.134
Own earn%
8.08
147.47
124.65
Sh yield%
46.01
37.61
35.29
Owners
Insiders/Inst%
14.81
59.22
Short interest%
5.86
SBC / revenue%
5.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
14